Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117
28 August 2013 - 11:00PM
Business Wire
Rexahn Retains its Rights to Cancer
Treatment Compound RX-3117
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Rexahn Pharmaceuticals, Inc. (American Stock Exchange): 0 recent articles
More Rexahn Pharmaceuticals News Articles